Nisa Investment Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Nisa Investment Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.9K	Sell	604 -30	-5%	-$2.62K	﹤0.01%	1790
2026 Q1	$53.2K	Buy	634 +419	+195%	+$24.3K	﹤0.01%	1642
2025 Q4	$8.86K	Buy	215 +165	+330%	+$6.4K	﹤0.01%	2275
2025 Q3	$1.97K	Hold	50	–	–	﹤0.01%	2624
2025 Q2	$932	Sell	50 -40	-44%	-$750	﹤0.01%	2748
2025 Q1	$1.63K	Buy	90 +72	+400%	+$1.59K	﹤0.01%	2521
2024 Q4	$392	Sell	18 -55	-75%	-$1.41K	﹤0.01%	2869
2024 Q3	$2K	Buy	+73	New	+$2.03K	﹤0.01%	2400
2022 Q2	–	Sell	-500	Closed	-$23K	–	2401
2022 Q1	$23K	Buy	+500	New	+$27.3K	﹤0.01%	2021
2021 Q4	–	Sell	-962	Closed	-$112K	–	2265
2021 Q3	$112K	Buy	+962	New	+$112K	﹤0.01%	1646

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Nisa Investment Advisors's DNTH Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Dianthus Therapeutics (DNTH) stake by 4.7% in Q2 2026, selling an estimated $2.62K and leaving 604 shares worth $58.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Nisa Investment Advisors first reported a position in DNTH in Q3 2021 and has held it in 10 quarters since. The position peaked at $112K in Q3 2021. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Nisa Investment Advisors held 604 shares of Dianthus Therapeutics worth $58.9K as of Q2 2026.
Nisa Investment Advisors sold 30 Dianthus Therapeutics shares in Q2 2026, an estimated $2.62K.
Dianthus Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1790 holding.
Nisa Investment Advisors first reported a position in Dianthus Therapeutics in Q3 2021 and has held it in 10 quarters since.
Nisa Investment Advisors's Dianthus Therapeutics position peaked at $112K in Q3 2021.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.